Thirty years of unhealthy evasion
Eleven babies have died in the space of a three-month period in the Neonatal Intensive Care Unit (NICU) at the Port of Spain General Hospital (PoSGH).Seven of these 11 deaths
Source: trinidadexpress.com
Infectious Agents News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Infectious Agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Infectious Agents Today - Breaking & Trending Today
Takedas GAMMAGARD LIQUID Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy CIDP
Takeda TSE4502NYSETAK today announced that the U.S. Food and Drug Administration FDA has approved GAMMAGARD LIQUID Immune Globulin Infusion Human 10 solution as an intravenous immunoglobulin IVIG therapy to improve neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy CIDP.
Source: businesswireindia.com
Takeda's GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -January 29, 2024 at 11:11 am EST
New Indication Delivers on Takeda’s Commitment to Expanding its Broad and Diverse Immunoglobulin Portfolio to Meet the Needs of People Living with CIDP Approval Supported by Phase 3...
Source: marketscreener.com
U.S. FDA Approves Takeda's HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -January 16, 2024 at 08:10 am EST
HYQVIA [Immune Globulin Infusion 10% with Recombinant Human Hyaluronidase], the Only up to Once Monthly Subcutaneous Immunoglobulin Infusion to Treat CIDP, Can Be Administered by a Healthcare...
Source: marketscreener.com
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
/PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous,...
Source: prnewswire.com